481 related articles for article (PubMed ID: 26056031)
1. Dynorphin activation of kappa opioid receptor reduces neuronal excitability in the paraventricular nucleus of mouse thalamus.
Chen Z; Tang Y; Tao H; Li C; Zhang X; Liu Y
Neuropharmacology; 2015 Oct; 97():259-69. PubMed ID: 26056031
[TBL] [Abstract][Full Text] [Related]
2. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
[TBL] [Abstract][Full Text] [Related]
3. Activation of κ opioid receptors increases intrinsic excitability of dentate gyrus granule cells.
McDermott CM; Schrader LA
J Physiol; 2011 Jul; 589(Pt 14):3517-32. PubMed ID: 21606111
[TBL] [Abstract][Full Text] [Related]
4. Direct inhibition of hypothalamic proopiomelanocortin neurons by dynorphin A is mediated by the μ-opioid receptor.
Pennock RL; Hentges ST
J Physiol; 2014 Oct; 592(19):4247-56. PubMed ID: 25085890
[TBL] [Abstract][Full Text] [Related]
5. Direct inhibition of arcuate proopiomelanocortin neurons: a potential mechanism for the orexigenic actions of dynorphin.
Zhang X; van den Pol AN
J Physiol; 2013 Apr; 591(7):1731-47. PubMed ID: 23318874
[TBL] [Abstract][Full Text] [Related]
6. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
[TBL] [Abstract][Full Text] [Related]
7. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
[TBL] [Abstract][Full Text] [Related]
8. Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice.
Anderson RI; Lopez MF; Griffin WC; Haun HL; Bloodgood DW; Pati D; Boyt KM; Kash TL; Becker HC
Neuropsychopharmacology; 2019 May; 44(6):1084-1092. PubMed ID: 30555162
[TBL] [Abstract][Full Text] [Related]
9. Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.
Margolis EB; Hjelmstad GO; Bonci A; Fields HL
J Neurosci; 2003 Nov; 23(31):9981-6. PubMed ID: 14602811
[TBL] [Abstract][Full Text] [Related]
10. Opioid-mediated modulation of calcium currents in striatal and pallidal neurons following reserpine treatment: focus on kappa response.
Spadoni F; Martella G; Martorana A; Lavaroni F; D'Angelo V; Bernardi G; Stefani A
Synapse; 2004 Mar; 51(3):194-205. PubMed ID: 14666517
[TBL] [Abstract][Full Text] [Related]
11. Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis.
Erikson CM; Wei G; Walker BM
Neuropharmacology; 2018 Sep; 140():162-173. PubMed ID: 30075159
[TBL] [Abstract][Full Text] [Related]
12. Species differences in the effects of the κ-opioid receptor antagonist zyklophin.
Sirohi S; Aldrich JV; Walker BM
Alcohol; 2016 Mar; 51():43-9. PubMed ID: 26992699
[TBL] [Abstract][Full Text] [Related]
13. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
[TBL] [Abstract][Full Text] [Related]
14. Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor.
Merg F; Filliol D; Usynin I; Bazov I; Bark N; Hurd YL; Yakovleva T; Kieffer BL; Bakalkin G
J Neurochem; 2006 Apr; 97(1):292-301. PubMed ID: 16515546
[TBL] [Abstract][Full Text] [Related]
15. Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay.
Zhao Y; Joshi AA; Aldrich JV; Murray TF
Biomed Pharmacother; 2021 Nov; 143():112173. PubMed ID: 34536757
[TBL] [Abstract][Full Text] [Related]
16. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.
Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C
J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence.
Matzeu A; Kallupi M; George O; Schweitzer P; Martin-Fardon R
Neuropsychopharmacology; 2018 Apr; 43(5):1010-1020. PubMed ID: 29052613
[TBL] [Abstract][Full Text] [Related]
18. Intracellular postsynaptic cannabinoid receptors link thyrotropin-releasing hormone receptors to TRPC-like channels in thalamic paraventricular nucleus neurons.
Zhang L; Kolaj M; Renaud LP
Neuroscience; 2015 Dec; 311():81-91. PubMed ID: 26470810
[TBL] [Abstract][Full Text] [Related]
19. Protracted withdrawal from ethanol and enhanced responsiveness stress: regulation via the dynorphin/kappa opioid receptor system.
Gillett K; Harshberger E; Valdez GR
Alcohol; 2013 Aug; 47(5):359-65. PubMed ID: 23731692
[TBL] [Abstract][Full Text] [Related]
20. Reduction of arcuate kappa-opioid receptor-expressing cells increased luteinizing hormone pulse frequency in female rats.
Dai M; Nakamura S; Takahashi C; Sato M; Munetomo A; Magata F; Uenoyama Y; Tsukamura H; Matsuda F
Endocr J; 2021 Aug; 68(8):933-941. PubMed ID: 33867395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
